While reporting financial results for the fourth quarter on Monday, biotechnology company Revvity, Inc. (RVTY) initiated its adjusted earnings and total revenue guidance for the full-year 2026.
For fiscal 2026, the company now projects adjusted earnings in a range of $5.35 to $5.45 per share on total revenues between $2.96 billion and $2.99 billion.
On average, analysts polled expect the company to report earnings of $5.32 per share on revenues of $2.94 billion for the year. Analysts' estimates typically exclude special items.
In Monday's pre-market trading, RVTY is trading on the NYSE at $109.94, up $1.14 or 1.05 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.